PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12016742::ACT015710

GI

Evidence text

Paper-level observation

number of anti‐tumor/pro‐inflammatory tumor‐associated macrophages (TAMs) (P = 0.0404) (Figure 5i) within the TME of mice treated with StCl‐GI_GII + αPD‐1 compared to mice treated with PBS or TAAs + αPD‐1.
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Antibacterial
Measure
percent_inhibition
Comparator
=
Raw observation
P = 0.0404 vs PBS and TAAs + αPD-1
Normalized measurement
=0.0404
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Mus musculus
Assay method
Not reported by source
Sequence
EGSRNQDWL
Standardization
ready simple

Source publication

Off‐The‐Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma

Advanced Materials · 2025

DOI 10.1002/adma.202417348 PMC12016742
Parent mention

Related peptide identities

PEPDIA-PLP-000563

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.